Evidence map›Paper›PMID 36219481›Full record

ArticleJCI insight2022

Airway surface hyperviscosity and defective mucociliary transport by IL-17/TNF-α are corrected by β-adrenergic stimulus.

Daniela Guidone, Martina Buccirossi, Paolo Scudieri, Michele Genovese, Sergio Sarnataro, Rossella De Cegli, Federico Cresta, Vito Terlizzi, Gabrielle Planelles, Gilles Crambert and 2 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Evaluation of ATP12A and NFKBIZ as potential markers of inflammatory status in cystic fibrosis airway epithelial cells.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Solute Carrier Family 26 Member 4 (SLC26A4), A Potential Therapeutic Target for Asthma.Journal of respiratory biology and translational medicine · 2024
    Article
  13. Dynamic regulation of airway surface liquid pH by TMEM16A and SLC26A4 in cystic fibrosis nasal epithelia with rare mutations.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Daniela GuidoneTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
Martina BuccirossiTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
Paolo ScudieriU.O.C. Genetica Medica, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Michele GenoveseTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
Sergio SarnataroTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
Rossella De CegliTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
Federico CrestaCentro Fibrosi Cistica, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Vito TerlizziMeyer Children's Hospital, Cystic Fibrosis Regional Reference Center, Department of Paediatric Medicine, Firenze, Italy.
Gabrielle PlanellesCentre de Recherche des Cordeliers, INSERM UMRS 1138, Sorbonne Université, Université Paris Cité, Paris, France.
Gilles CrambertCentre de Recherche des Cordeliers, INSERM UMRS 1138, Sorbonne Université, Université Paris Cité, Paris, France.
Isabelle SermetInstitut Necker Enfants Malades/INSERM U1151, Paris, France.
Luis Jv GaliettaTelethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
Telethon Institute Of Genetics And Medicine · ITCentre National de la Recherche Scientifique · FRIstituto Giannina Gaslini · ITFederico II University Hospital · ITInserm · FRMeyer Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fluid covering the surface of airway epithelia represents a first barrier against pathogens. The chemical and physical properties of the airway surface fluid are controlled by the activity of ion channels and transporters. In cystic fibrosis (CF), loss of CFTR chloride channel function causes airway surface dehydration, bacterial infection, and inflammation. We investigated the effects of IL-17A plus TNF-α, 2 cytokines with relevant roles in CF and other chronic lung diseases. Transcriptome analysis revealed a profound change with upregulation of several genes involved in ion transport, antibacterial defense, and neutrophil recruitment. At the functional level, bronchial epithelia treated in vitro with the cytokine combination showed upregulation of ENaC channel, ATP12A proton pump, ADRB2 β-adrenergic receptor, and SLC26A4 anion exchanger. The overall result of IL-17A/TNF-α treatment was hyperviscosity of the airway surface, as demonstrated by fluorescence recovery after photobleaching (FRAP) experiments. Importantly, stimulation with a β-adrenergic agonist switched airway surface to a low-viscosity state in non-CF but not in CF epithelia. Our study suggests that CF lung disease is sustained by a vicious cycle in which epithelia cannot exit from the hyperviscous state, thus perpetuating the proinflammatory airway surface condition.

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorAdrenergic AgentsCytokinesEpithelial CellsH(+)-K(+)-Exchanging ATPaseHumansInterleukin-17Mucociliary ClearanceTumor Necrosis Factor-alphaAdrenergic AgentsATP12A protein, humanCystic Fibrosis Transmembrane Conductance RegulatorCytokinesH(+)-K(+)-Exchanging ATPaseInterleukin-17Tumor Necrosis Factor-alphaInnate immunityIon channelsPulmonology

Identifiers

PMID36219481
PMCPMC9746827
OpenAlexW4304203197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.